Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002336 · ClinicalTrials.gov registry record · NA
The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
A NA study, sponsored by Abbott.
- Completed
- Registry status
- NA
- Development phase
NCT00002336: Completed NA study, sponsored by Abbott.
NCT00002336 is a NA study that has completed, run by Abbott. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002336, a NA study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To determine whether clarithromycin is safe and effective in preventing disseminated Mycobacterium avium Complex in HIV-infected patients with CD4 counts \<= 100 cells/mm3.
Interventions
- DRUG Clarithromycin
Trial Details
| Field | Value |
|---|---|
| Start Date | 1992-11 |
| Est. Completion | 1994-11 |
| Phase | NA |
What the finished NCT00002336 record still lists
NCT00002336 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Clarithromycin is the first listed.
NCT00002336 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002336 about?
NCT00002336 is a clinical study titled "The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients". To determine whether clarithromycin is safe and effective in preventing disseminated Mycobacterium avium Complex in HIV-infected patients with CD4 counts \<= 100 cells/mm3.
What is the current status of trial NCT00002336?
This trial is currently completed. It is a NA study. The study started on 1992-11. Estimated completion is 1994-11.
What interventions are being tested in trial NCT00002336?
The interventions under investigation include: Clarithromycin (DRUG).
Who is sponsoring clinical trial NCT00002336?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia